AMD3100 modulates the secretome responses of human Mesenchymal Stromal Cells but not their inhibitory effect on T cell proliferation
Rhett N. Parr, Sara Temple, Maya Brown, Denton Lord, Isabella Hogan, Keenan Hogan, Lawson Blake, Yenamala U. Reddy, Devi Rajan, Peiman Hematti, Raghavan Chinnadurai · 2026
Read AMD3100 modulates the secretome responses of human Mesenchymal Stromal Cells but not their inhibitory effect on T cell proliferation by Rhett N. Parr, Sara Temple, Maya Brown, Denton Lord, Isabella Hogan, Keenan Hogan, Lawson Blake, Yenamala U. Reddy, Devi Rajan, Peiman Hematti, Raghavan Chinnadurai (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13381542.txt.
Description
Rhett Parr and co-authors test what a stem cell mobilizing drug does to helper cells in the bone marrow, in this 2026 study. The drug, AMD3100, moves blood stem cells into the blood for transplant collection. The helper cells, mesenchymal stromal cells, calm immune responses and release many signaling molecules.
The drug left the helper cells' metabolism alone but changed what they secrete. Under inflammatory stimulation, treated cells released more attracting chemicals and made more of a calming enzyme. In mixed cultures, the cells still slowed T cell growth just as well with the drug present. Secretions in those mixes shifted, though. The authors say the drug reshapes the marrow's chemical climate without blunting one key cell therapy effect.
Catalog record
| CREATOR | Rhett N. Parr, Sara Temple, Maya Brown, Denton Lord, Isabella Hogan, Keenan Hogan, Lawson Blake, Yenamala U. Reddy, Devi Rajan, Peiman Hematti, Raghavan Chinnadurai |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |